Application of the 940 nm laser combined with propranolol in treating infantile hemangioma with supplying vessels
10.3760/cma.j.cn114453-20200305-00108
- VernacularTitle:940 nm激光联合普萘洛尔在伴供血血管婴幼儿血管瘤治疗中的应用
- Author:
Yang GAO
1
;
Xiang WANG
;
Yifan YANG
;
Lei XUE
;
Qi LIU
;
Fangfang LI
;
Wenxian ZHANG
Author Information
1. 河北医科大学附属河北省儿童医院整形外科，石家庄 050031
- Keywords:
Infantile hemangioma;
Propranolol;
Lasers, semiconductor;
Blood supply vessel
- From:
Chinese Journal of Plastic Surgery
2021;37(6):619-623
- CountryChina
- Language:Chinese
-
Abstract:
Objective:To investigate the value of the 940 nm laser combined with propranolol to treat the infantile hemangioma with supplying vessels.Methods:From December 2017 to December 2018, when oral propranolol was ineffective, the color Doppler ultrasound and magnetic resonance imaging were performed on 22 infants with hemangioma in the Department of Plastic Surgery of Hebei Children’s Hospital. There were 7 males and 15 females, aged from 4 to 35 months, with an average age of 13.1 months. In 21 cases of hemangioma with clear supplying vessels under digital subtraction angiography, the patients were treated with the 940 nm semiconductor laser occlusion treatment and postoperative oral propranolol therapy. Color Doppler ultrasound was used to measure the tumor size and detect blood flow signal to determine the regression of hemangioma.Results:Among the 21 cases, 19 cases gradually subsided after one 940 nm semiconductor laser occlusion treatment, with an effective rate of 90.5%. Another two cases subsided after two occlusion treatments.Conclusions:The effect of propranolol in treating infantile hemangioma with supplying vessels is often poorly effective. Using the 940 nm semiconductor laser to block the supplying vessel can promote the regression of hemangioma effectively.
